Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
5721 studies found for:    stem cell
Show Display Options
RSS Create an RSS feed from your search for:
stem cell
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
21 Not yet recruiting Adipose Tissue Derived Stem Cell Based Hair Restoration Therapy for Androgenetic Alopecia
Condition: Hair Restoration Using Autologous Mesenchymal Stem Cells
Interventions: Drug: stem cells;   Drug: platelet rich plasma
22 Active, not recruiting Bortezomib, Melphalan, and Total-Body Irradiation Before Stem Cell Transplant in Treating Patients With Multiple Myeloma
Conditions: DS Stage I Plasma Cell Myeloma;   DS Stage II Plasma Cell Myeloma;   DS Stage III Plasma Cell Myeloma;   Refractory Plasma Cell Myeloma
Interventions: Drug: Bortezomib;   Radiation: Total-Body Irradiation;   Drug: Melphalan;   Procedure: Autologous Bone Marrow Transplantation;   Procedure: Autologous Hematopoietic Stem Cell Transplantation;   Procedure: Peripheral Blood Stem Cell Transplantation;   Other: Laboratory Biomarker Analysis
23 Completed Stem Cell Transplantation for Patients With Hematologic Malignancies
Conditions: Acute Lymphoblastic Leukemias;   Acute Myelocytic Leukemia;   Chronic Myeloid Leukemia;   Juvenile Myelomonocytic Leukemia;   Myelodysplastic Syndrome;   Hemoglobinuria, Paroxysmal;   Non-Hodgkin Lymphoma
Interventions: Procedure: Allogeneic Stem Cell Transplantation;   Drug: Chemotherapy and antibodies
24 Completed Mesenchymal Stem Cells in Knee Cartilage Injuries
Conditions: Articular Cartilage Disorder of Knee;   Osteoarthritis, Knee
Intervention: Biological: Autologous Mesenchymal Stem Cells
25 Completed Trial of Allogeneic Stem Cell Transplants From HLA Compatible, Related and Unrelated Donors After a Myeloablative Preparative Regimen With Hyperfractionated TBI, Thiotepa and Fludarabine For Adult Patients With Lymphohematopoietic Disorders
Conditions: Allogeneic Stem Cell Transplant;   Leukemia;   Non-Hodgkins;   Lymphoblastic Lymphoma;   Myelodysplastic Syndrome;   Paroxysmal Nocturnal Hemoglobinuria (PNH)
Intervention: Drug: cytoreductive regimen followed by a CD34+E- selected allogeneic stem cell transplant
26 Unknown  Stem Cell Educator Therapy in Type 1 Diabetes
Condition: Type 1 Diabetes
Intervention: Device: Stem Cell Educator
27 Completed Human Neural Stem Cell Transplantation in Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis
Intervention: Biological: Human Neural Stem Cells
28 Unknown  Intramuscular Injection of Mesenchymal Stem Cell for Treatment of Children With Idiopathic Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Intervention: Biological: umbilical cord mesenchymal stem cells
29 Active, not recruiting Effect Of Mesenchymal Stem Cells Transfusion on the Diabetic Peripheral Neuropathy Patients .
Condition: Diabetic Peripheral Neuropathy
Intervention: Genetic: mesenchymal stem cells
30 Terminated Hematopoietic Stem Cell Support in Patients With Refractory Sarcoidosis
Condition: Sarcoidosis
Interventions: Biological: Autologous hematopoietic stem cell transplantation;   Biological: Allogeneic stem cell transplantation
31 Withdrawn Stem Cells for the Improvement of Erectile and Cardiac Function in Aging Men
Conditions: Erectile Dysfunction;   Cardiac Disease
Interventions: Biological: ARM 1: AdMSC: adipose stem cells;   Other: ARM 2: Placebo
32 Completed Trial of Two Stem Cell Doses To Reduce Transplant Induced Symptom Burden
Conditions: Multiple Myeloma;   Primary Amyloidosis
Interventions: Drug: Melphalan;   Procedure: Stem Cell Infusion;   Behavioral: Questionnaires;   Drug: Granulocyte-colony stimulating factor (G-CSF);   Procedure: Apheresis
33 Completed Effect of Intrathecal Administration of Hematopoietic Stem Cells in Patients With Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis
Intervention: Biological: Intrathecal autologous stem cell
34 Completed Hematopoietic Stem Cell Transplantation in Type 1 Diabetes Mellitus
Condition: Type 1 Diabetes Mellitus
Intervention: Procedure: Autologous hematopoietic stem cell transplantation
35 Completed Busulfan and Etoposide Followed by Peripheral Blood Stem Cell Transplant and Low-Dose Aldesleukin in Treating Patients With Acute Myeloid Leukemia
Conditions: Adult Acute Myeloid Leukemia in Remission;   Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities;   Adult Acute Myeloid Leukemia With Del(5q);   Adult Acute Myeloid Leukemia With t(15;17)(q22;q12);   Adult Acute Myeloid Leukemia With t(16;16)(p13;q22);   Childhood Acute Myeloid Leukemia in Remission;   Recurrent Adult Acute Myeloid Leukemia;   Recurrent Childhood Acute Myeloid Leukemia
Interventions: Drug: busulfan;   Drug: etoposide;   Biological: aldesleukin;   Procedure: peripheral blood stem cell transplantation
36 Completed "It is a Real" The First Baby Of Autologous Stem Cell Therapy in Premature Ovarian Failure
Condition: Premature Ovarian Failure
Intervention: Biological: Stem cell
37 Completed
Has Results
Sm-EDTMP and Autologous Peripheral Blood Stem Cell Transplantation for Breast Cancer Patients With Bone Only Metastases
Conditions: Breast Cancer;   Bone Metastases
Interventions: Drug: 153 Sm-EDTMP;   Behavioral: Questionnaire;   Procedure: Stem Cell Transplant
38 Recruiting Panobinostat Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant for Patients With Refractory/Relapsed Myeloma
Condition: Multiple Myeloma
Interventions: Drug: Busulfan;   Drug: Palifermin;   Drug: Panobinostat;   Drug: Gemcitabine;   Drug: Melphalan;   Drug: Dexamethasone acetate;   Drug: Caphosol;   Drug: Glutamine;   Drug: Pyridoxine;   Procedure: Stem Cell Transplant
39 Recruiting ABCB5 as a Prognostic Marker in Survival of Cultivated Limbal Stem Cell Transplantation
Condition: Limbal Stem Cell Deficiency
Interventions: Procedure: Pannus and conjunctival dissection;   Procedure: Human cultivated limbal stem cell transplantation
40 Active, not recruiting Treatment of Optic Neuropathies Using Autologous Bone Marrow-Derived Stem Cells
Condition: Optic Neuropathy
Intervention: Biological: Stem Cells

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years